McKinsey's $650M Opioid Settlement Sends Warning to Consultants

1 min read
Source: Financial Times
McKinsey's $650M Opioid Settlement Sends Warning to Consultants
Photo: Financial Times
TL;DR

McKinsey has agreed to a $650 million settlement with the US Department of Justice over its role in advising opioid manufacturers, including Purdue Pharma, during the opioid crisis. The firm admitted to conspiring to misbrand prescription drugs and will face restrictions on future pharmaceutical consulting work. A former senior partner, Martin Elling, will plead guilty to obstructing justice by destroying documents. This marks the first criminal accountability for a consulting firm in such a case, highlighting the legal risks for consultants involved in client misconduct.

Share this article

Want the full story? Read the original reporting

Read on Financial Times